MENU
GOSS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Gossamer Bio (GOSS) Earnings Date & Reports
Gossamer Bio Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Pharmaceuticals Major
A.I. Advisor
published Earnings
GOSS is expected to report earnings to fall 41.85% to -11 cents per share on August 11
Q2'26
Est.
$-0.12
Q1'26
Missed
by $0.03
Q4'25
Missed
by $0.02
Q3'25
Missed
by $0.02
Q2'25
Beat
by $0.01
The last earnings report on May 18 showed earnings per share of -20 cents, missing the estimate of -17 cents. With 8.94M shares outstanding, the current market capitalization sits at 80.27M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a company, which engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology
Industry Biotechnology
Profile
Details
Industry
Pharmaceuticals Major
Address
3115 Merryfield Row
Phone
+1 858 684-1300
Employees
162
Web
https://www.gossamerbio.com